CODEXIS INC. - COMMON

Codexis and Nestlé Health Science Initiate a Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency

03 11 2021 16:05:00 提供 Nasdaq GlobeNewswire

Codexis to Report Third Quarter 2021 Financial Results on November 4

21 10 2021 16:05:00 提供 Nasdaq GlobeNewswire

Codexis, Almelo and RC2 Announce a Tri-Party Collaboration for the Enzymatic Production of Low Cost Sitagliptin API for the Generic Market, Including a License to Codexis Enzyme Technology in India

18 10 2021 08:00:01 提供 Nasdaq GlobeNewswire

Codexis and Merck Amend and Extend Supply Agreement for Enzyme Used in Manufacture of Sitagliptin

09 9 2021 16:05:00 提供 Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Virtual Healthcare Conferences

07 9 2021 16:05:00 提供 Nasdaq GlobeNewswire

Codexis Confirms Receipt of Follow-on Orders for Proprietary Enzyme Product from Undisclosed Global Pharmaceutical Company

25 8 2021 16:05:00 提供 Nasdaq GlobeNewswire

Codexis Reports Second Quarter 2021 Financial Results

05 8 2021 16:05:03 提供 Nasdaq GlobeNewswire

Codexis and Kalsec Announce Expanded Collaboration for Supply of Novel Enzyme to Sustainably Produce Natural Clean-Label Beverage Ingredient

02 8 2021 08:00:01 提供 Nasdaq GlobeNewswire

Codexis and Kalsec Announce Expanded Collaboration for Supply of Novel Enzyme to Sustainably Produce Natural Clean-Label Beverage Ingredient

26 7 2021 16:05:00 提供 Nasdaq GlobeNewswire

Codexis to Report Second Quarter 2021 Financial Results on August 5

22 7 2021 16:05:01 提供 Nasdaq GlobeNewswire

Codexis Announces Completion of CodeEvolver® License Technology Transfer with Global Pharmaceutical Leader

14 7 2021 16:05:00 提供 Nasdaq GlobeNewswire

Codexis Earns Milestone Payment from GlaxoSmithKline

07 7 2021 16:05:00 提供 Nasdaq GlobeNewswire

Codexis Raises 2021 Guidance Following Receipt of Significant New Order for a Proprietary Enzyme Product

17 6 2021 16:44:08 提供 Nasdaq GlobeNewswire

Codexis and Takeda Expand Strategic Collaboration and License Agreement to Discover Additional Gene Therapy for a Fourth Rare Genetic Disorder

10 6 2021 07:00:00 提供 Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Virtual Healthcare Conferences

25 5 2021 16:05:00 提供 Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Virtual Healthcare Conferences

17 5 2021 16:05:00 提供 Nasdaq GlobeNewswire

Codexis Reports First Quarter 2021 Financial Results

06 5 2021 16:05:01 提供 Nasdaq GlobeNewswire

Codexis to Report First Quarter 2021 Financial Results on May 6

22 4 2021 16:05:00 提供 Nasdaq GlobeNewswire

Codexis Reports Fourth Quarter and Fiscal Year 2020 Financial Results

25 2 2021 16:05:03 提供 Nasdaq GlobeNewswire

Codexis to Present at Upcoming Virtual Healthcare Conferences

18 2 2021 16:05:01 提供 Nasdaq GlobeNewswire